Detalhe da pesquisa
1.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278078
2.
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.
Int J Mol Sci
; 20(7)2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986912
3.
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.
Cancers (Basel)
; 14(18)2022 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139625
4.
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.
EMBO Mol Med
; 11(7): e10293, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273938